11-72107962-C-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001393500.2(TOMT):c.299C>A(p.Ala100Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000058 in 1,551,600 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A100P) has been classified as Likely benign.
Frequency
Consequence
NM_001393500.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TOMT | NM_001393500.2 | c.299C>A | p.Ala100Asp | missense_variant | 2/3 | ENST00000541899.3 | |
LRTOMT | NM_001145309.4 | c.398C>A | p.Ala133Asp | missense_variant | 8/9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TOMT | ENST00000541899.3 | c.299C>A | p.Ala100Asp | missense_variant | 2/3 | 5 | NM_001393500.2 | P1 | |
ANAPC15 | ENST00000502597.2 | c.64-357G>T | intron_variant | 1 | |||||
ANAPC15 | ENST00000543050.5 | c.319-357G>T | intron_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152182Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000128 AC: 2AN: 156646Hom.: 0 AF XY: 0.0000241 AC XY: 2AN XY: 83002
GnomAD4 exome AF: 0.00000500 AC: 7AN: 1399418Hom.: 0 Cov.: 31 AF XY: 0.00000869 AC XY: 6AN XY: 690222
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152182Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74354
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 01, 2024 | The c.398C>A (p.A133D) alteration is located in exon 6 (coding exon 4) of the LRTOMT gene. This alteration results from a C to A substitution at nucleotide position 398, causing the alanine (A) at amino acid position 133 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at